Not Many Employers Cover GLP-1 Weight Loss Drugs
Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.
The Unexplored Effects of Weight-Loss Drugs on the Brain
Popular weight-loss drugs like Ozempic are used to treat obesity and diabetes. Now, researchers found that these drugs also affect rodent brains in other ways.
The FDA issued a warning about compounding pharmacies on weight-loss drugs
A surge of alternatives to newly popular weight-loss drugs is facing its biggest test yet after the FDA warned companies against skirting regulatory standards to put them on the market now that shortages are waning.
FDA says shortage of popular diabetes, weight-loss drugs resolved
The FDA says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — has been resolved.
Eli Lilly’s weight-loss and diabetes drugs are no longer in shortage, says FDA
The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage signaling that the company has succeeded in expanding manufacturing.
Lilly's weight-loss drug removed from FDA's shortage list
The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list late on Wednesday, likely piling pressure on firms selling cheaper versions known as compounded drugs.
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
Eli Lilly’s (NYSE:LLY) blockbuster GLP-1 medication, tirzepatide, is no longer in shortage in the U.S., the U.S. Food and Drug Administration (FDA) said on Wednesday. Tirzepatide, currently marketed by Eli Lilly (LLY) as Mounjaro and Zepbound for diabetes and weight loss,
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
Men, Baby Boomers, and postgraduate degree-holders were among those most likely to say they wouldn’t choose medication over ...
Ozempic is driving up the cost of your health care, whether you can get your hands on it or not
About 165 million Americans rely on employer-sponsored health insurance, and yet workers may still not get the coverage they ...
Benzinga.com on MSN22h
Criminal Networks Cash In On Demand For Weight Loss Drugs, Authorities Say
Last week, the FDA determined the shortage of Eli Lilly tirzepatide injection, a glucagon-like peptide 1 (GLP-1) ...
NBC 10 Philadelphia2d
Surging demand leaves many without crucial diabetes and ADHD medications
Ozempic is in a class of medication called GLP-1, or glucagon-like peptide 1, agonists, which are primarily used to ...
News Medical on MSN4d
GLP-1 drugs protect brain health by improving neurovascular function and reducing inflammation
Research highlights how GLP-1 receptor agonists may improve brain health by targeting the neurovascular unit, linking ...
Modern Healthcare1d
This is what buyers of digital health solutions want in a partner
Most digital health purchasers plan to increase their investments next year and are asking for risk-based contracts.
Pharmaceutical Technology1mon
Glucagon Like Peptide 1 drugs in development, 2024
GlobalData’s report assesses the drugs in the Glucagon Like Peptide 1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
thorax.bmj11d
Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD
Background Clinical studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RA) can have beneficial effects ...
Des Moines Register3d
Premiums this year may surprise you: Why health insurance is getting more expensive
Other companies require that employees enroll in a weight loss program before or while taking one of the new class of weight ...
National Academies of Sciences%2c Engineering%2c and Medicine3mon
Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for Central Nervous System Disorders: A Workshop
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
The American Journal of Managed Care1d
Legislative Updates, GLP-1s, and More at AMCP Nexus: Adam Colborn
Speakers from across the care continuum will discuss legislative updates, glucagon-like peptide-1 (GLP-1) use for weight management, and more at this year’s AMCP Nexus.